Stay updated on DARA/ATRA Combo in Myeloma: Clinical Trial
Sign up to get notified when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.
Latest updates to the DARA/ATRA Combo in Myeloma: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 was added and v3.3.1 removed on the page header. This change updates only the page version metadata and does not modify study content or results.SummaryDifference0.1%
- Check21 days agoChange DetectedThe Publications section text was updated to clarify that publications are provided voluntarily by the study entrants and may be auto-filled from PubMed, with revision from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check28 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics; removed the government funding operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%
- Check43 days agoChange Detected- The related topics section no longer includes 'Multiple myeloma' and 'MedlinePlus Genetics'.SummaryDifference0.6%
- Check64 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma, narrowing the page’s health topic coverage.SummaryDifference0.2%
- Check71 days agoChange Detected- Added a government funding lapse notice with status guidance and links; updated operating details for NIH Clinical Center. - Bumped revision from v3.1.0 to v3.2.0.SummaryDifference2%
Stay in the know with updates to DARA/ATRA Combo in Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DARA/ATRA Combo in Myeloma: Clinical Trial page.